Cravath, Swaine & Moore LLP Logo
  • Practices
  • People
  • Careers
  • News & Insights
  • Practices
  • People
  • Careers
  • News & Insights
  • Our Story
  • The Cravath System
  • Diversity & Inclusion
  • Pro Bono
  • Alumni Journal
  • 200.Cravath

Cravath’s London Office Moves to 100 Cheapside

Read More

News & Insights

Law360 Names Cravath a 2022 “M&A Practice Group of the Year”

January 20, 2023

On January 18, 2023, Cravath was featured by Law360 as an “M&A Practice Group of the Year,” receiving the distinction for the tenth time in twelve years. The profile highlighted the Firm’s role representing CyrusOne in its $15 billion acquisition by KKR and Global Infrastructure Partners, SMBC Aviation Capital in its $6.7 billion acquisition of Goshawk Aviation, and Johnson & Johnson in the planned separation of its Consumer Health Business.

Cravath partner Robert I. Townsend III noted Cravath’s long‑term relationship with clients such as CyrusOne and J&J, and mentioned that the latter’s upcoming transaction should be the largest spinoff ever. “We want to make sure we execute things perfectly for them since they care so much about the businesses that they own and operate,” he added.

Please click here to read the feature.

Related Practices & Industries

  • Corporate
  • Mergers and Acquisitions
  • Private Equity
  • Technology
  • Real Estate and Hospitality
  • Transportation
  • Industrials and Chemicals
  • Financial Services and Insurance
  • Healthcare and Life Sciences
  • Consumer Products and Services

People

Photo
Name
Robert I. Townsend III
Title
Corporate
Title
Partner
Email
rtownsend@cravath.com
Phone
+1-212-474-1964
vCard
Download vCard

    Education

    • J.D., 1990, Harvard Law School
      magna cum laude
    • A.B., 1987, Harvard College
      magna cum laude

    Admitted In

    • New York

    Related News & Insights

    Deals & Cases

    November 15, 2021

    CyrusOne’s $15 Billion Acquisition by KKR and Global Infrastructure Partners

    On November 15, 2021, CyrusOne Inc. (“CyrusOne”), a premier global data center REIT, KKR, a leading investment firm, and Global Infrastructure Partners, a leading infrastructure investor, announced a definitive agreement pursuant to which KKR and GIP will acquire all outstanding shares of common stock of CyrusOne for $90.50 per share in an all‑cash transaction valued at approximately $15 billion, including the assumption of debt. Upon completion of the transaction, CyrusOne will be a privately held company wholly owned by KKR and GIP and CyrusOne’s common stock will no longer be listed on any public market. Cravath is representing CyrusOne in connection with the transaction.

    Deals & Cases

    May 16, 2022

    SMBC Aviation Capital’s $6.7 Billion Acquisition of Goshawk Aviation

    On May 16, 2022, SMBC Aviation Capital, one of the world’s leading aircraft leasing companies, announced that it has reached agreement with NWS Holdings Limited and Chow Tai Fook Enterprises Limited to acquire Goshawk Aviation (“Goshawk”), the Dublin‑based global aircraft lessor. Under the terms of the agreement, SMBC Aviation Capital will acquire Goshawk Management (Ireland), Goshawk’s Irish‑incorporated operating entity together with associated corporate assets for an enterprise value of $6.7 billion. The combined business will continue to operate as SMBC Aviation Capital and will consist of a single corporate structure incorporated in the Republic of Ireland, and will be the second largest leasing company by number of aircraft globally and the largest Japanese owned aircraft lessor. Cravath is representing SMBC Aviation Capital in connection with the transaction.

    Deals & Cases

    November 12, 2021

    Johnson & Johnson’s Planned Separation of its Consumer Health Business

    On November 12, 2021, Johnson & Johnson announced its intent to separate its Consumer Health business, creating a new publicly traded company. Following the planned separation, Johnson & Johnson would remain the world’s largest and most diverse healthcare company, with a portfolio that blends its Pharmaceutical and Medical Device capabilities. The New Consumer Health Company would be a leading global consumer health company with iconic brands such as Neutrogena, AVEENO®, Tylenol®, Listerine®, JOHNSON’s®, and BAND‑AID®. Cravath is representing Johnson & Johnson in connection with the planned transaction.

    Cravath Bicentennial

    Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.

    Explore

    Cravath, Swaine & Moore LLP Logo
    • CONTACT US
    • OUR STORY
    • ALUMNI PORTAL
    • DISCLAIMERS & NOTICES

    Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.